40% of chronic pain patients fully stopped opioids after starting medical cannabis, with 87% reporting improved quality of life

Of 525 chronic pain patients who used both medical cannabis and prescribed opioids, 40.4% stopped all opioids, 45.2% decreased use, 13.3% had no change, and only 1.1% increased opioid use. The majority (65.3%) sustained the opioid change for over a year. Nearly half (48.2%) reported 40-100% pain reduction. 80% reported improved functioning and 87% improved quality of life. 62.8% did not want to take opioids in the future.

Online convenience survey of patients from 3 medical cannabis practices who had used prescription opioids continuously for 3+ months for chronic pain and were concurrently using medical cannabis. 1,181 responded; 525 met criteria.

The 40% complete opioid cessation rate and 87% quality of life improvement are striking, even accounting for selection bias. If even a fraction of this effect is real, medical cannabis could be a powerful tool in the opioid crisis.

The 62.8% not wanting future opioids is particularly notable. Medical cannabis may not just reduce opioid doses but fundamentally change patient preferences away from opioids, potentially breaking the psychological attachment that contributes to dependence.

Convenience sample from cannabis practices (strong selection bias toward satisfied patients); self-report; no control group; survey cannot establish causation; patients choosing medical cannabis are already motivated to reduce opioids; no verification of opioid cessation.